A Randomized Clinical Study Based on Comparison Between Closure of Uterine Incision With Vicryl 2/0 Versus Vicryl 1 in Development of Uterine Niche.

Cesarean Section; Dehiscence Clinical Trial

Official title:

A Randomized Clinical Study Based on Comparison Between Closure of Uterine Incision With Vicryl 2/0 Versus Vicryl 1 in Development of Uterine Niche.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05770115
• Other study ID #: MS-467-2020
• Status: Completed
• Phase: N/A
• Start date: November 1, 2020
• Est. completion date: February 10, 2023

Study information

• Verified date: March 2023
• Source: Cairo University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The first group patients underwent double layer closure with split thickness with vicryl 2/0, in continuous, non- locked, 1 cm apart sutures, study group, and the second group, women underwent double layer closure with split thickness with vicryl 1, in continuous, non- locked, 1 cm apart sutures, control group. Then, all women in the study were followed up for development of niche within 1 to 6 weeks. The assessment after one week postpartum was with using trans-abdominal Ultrasound, then after two to six weeks postpartum with transvaginal Ultrasound

Description:

Caesarean section rates have increased worldwide over the past decades from 6.7 to 19.1%, with a current European CS rate of 25% of all births. CS is considered to be a safe procedure that can be life saving for both mother and child but the increasing trend draws more attention to adverse outcomes related to CSs. A relatively new long-term sequela is the niche in the uterine caesarean scar. A niche is defined as "an indentation at the site of the uterine caesarean scar with a depth of at least 2 mm on ultrasound" and is present in 56-84% of women after one or more CSs .

It is realized that almost all of the increase in cesarean section rate is due to the increase in repeat operations, and primary cesarean deliveries for dystocia and fetal distress. These can be attributed to obstetric factors as increased primary cesarean delivery rate, failed induction. Maternal factors as Increased proportion of women > age 35, increased nulliparous women, increased elective primary cesarean deliveries and factors relating to the physician as Malpractice litigation concerns .

The hypotheses can be divided into surgery-related factors and patient related factors. In their paper they focused on surgery-related factors since these could be easily modified and studied in future RCTs .

These surgical-related factors include low (cervical) location of the uterine incision during a CS, Incomplete closure of the uterine wall, due to single-layer, endometrial saving closure technique or use of locking sutures and Surgical activities that may induce adhesion formation (i.e., non-closure of peritoneum, inadequate hemostasis, applied sutures, use of adhesion barriers).

Without questions, the uterine niche presents a pathology that requires evaluation and intervention to mitigate its prevalence. The aim of this study is to compare between closures of uterine incision with Vicryl 2/0 versus Vicryl 1 in developing a uterine niche.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 264
• Est. completion date: February 10, 2023
• Est. primary completion date: December 15, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years to 40 Years

Eligibility

Inclusion Criteria:

• Singleton term pregnancy.

• Parity less than 5.

• Women who undergo 1st cesarean section whether in labor or not.

Exclusion Criteria:

• Women with a previous CS.

• Previous major uterine surgery (e.g. laparoscopic or laparotomic fibroid resection, septum resection).

• Women with known causes of menstrual disorders (e.g. cervical dysplasia, communicating hydro-salpinx, uterine anomaly or endocrine disorders disturbing ovulation).

• Abnormally invasive placenta during the current pregnancy.

• Multiple gestation, polyhydramnios.

• Maternal Diabetes, anemia and connective tissue disorders.

• Women with Body mass index > 35.

• Women with valval varicosities.

Related Conditions & MeSH terms

• Cesarean Section; Dehiscence

Intervention

Procedure:
• Vicryl 1
Double layer closure with split thickness with vicryl 1, in continuous, non-locked, 1 cm apart sutures.
• Vicryl 2/0
Double layer closure with split thickness with vicryl 2/0, in continuous, non-locked, 1 cm apart sutures.

Locations

Country	Name	City	State
Egypt	Kasr Alainy outpatient infertility clinic	Cairo

Sponsors (1)

Lead Sponsor	Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

References & Publications (3)

70. Monika & Gupta, Monika & Goraya, s.P.s & Kaur, Tanjeet & Matreja, Prithpal. (2017). Single Layer Versus Double Layer Closure of Uterus during Caesarean Section - A Prospective Study in Index and Subsequent Pregnancy. International Archives of BioMedical and Clinical Research. 1. 10.21276/iabcr.2017.3.1.14.

Bij de Vaate AJ, van der Voet LF, Naji O, Witmer M, Veersema S, Brolmann HA, Bourne T, Huirne JA. Prevalence, potential risk factors for development and symptoms related to the presence of uterine niches following Cesarean section: systematic review. Ultrasound Obstet Gynecol. 2014 Apr;43(4):372-82. doi: 10.1002/uog.13199. — View Citation

Byrne M, Aly A. The Surgical Suture. Aesthet Surg J. 2019 Mar 14;39(Suppl_2):S67-S72. doi: 10.1093/asj/sjz036. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	prevalence of uterine niche	using transvaginal ultrasound for detection of development of CS scar niche	6 weeks
Secondary	operative time	operative time in minutes is measured from the time of skin incision to time of skin closure	1 hour
Secondary	size of cs niche	size of cs niche is measured in millimeters using transvaginal ultrasound.	6 weeks
Secondary	operative blood loss	operative blood loss in milliliteres as indicated by the wieghing the towels before and after CS.	2 hours
Secondary	postoperative haemoglobin	measured in mg/dl as full blood count is done 24 hours postoperative.	24 hours